Edwards Lifesciences Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Edwards Lifesciences Corporation
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- EW
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001099800
Board of directors
-
Bernard J. Zovighian · Director · CEOSince 2022
-
David T. Feinberg · DirectorSince 2024
-
Heisz Leslie Stone · DirectorSince 2023
-
Kieran Gallahue · DirectorSince 2023
-
Leslie C. Davis · DirectorSince 2024
-
Martha H. Marsh · DirectorSince 2023
-
Michael A. Mussallem · Director · Chairman & CEOSince 2023
-
Nicholas J. Valeriani · DirectorSince 2023
-
Paul A. Laviolette · DirectorSince 2023
-
Ramona Sequeira · DirectorSince 2023
-
Steven R. Loranger · DirectorSince 2023
Chief executives
Michael A. Mussallem
· Chairman & CEO
Dates unknown
Bernard J. Zovighian
· CEO
Since May 2022
Board connections
7 of this board's directors also sit on 9 other boards.
- via Martha H. Marsh
- via David T. Feinberg
- via Kieran Gallahue
- via David T. Feinberg
- via Heisz Leslie Stone
- via Ramona Sequeira
- via Heisz Leslie Stone
- via Paul A. Laviolette
- via Steven R. Loranger
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $6,395,015
- 13 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | BOBO DONALD E JR Officer (CVP,Strategy/Corp Development) | Open-market sale | −5,486 | $83.79 | $459,682 |
| Dec 12, 2025 | Lippis Daniel J. Officer (CVP, JAPAC) | Option exercise | +1,019 | $59.26 | $60,386 |
| Dec 12, 2025 | Heisz Leslie Stone Director | Open-market sale | −2,615 | $83.41 | $218,117 |
| Dec 12, 2025 | BOBO DONALD E JR Officer (CVP,Strategy/Corp Development) | Open-market sale | −5,900 | $83.74 | $494,066 |
| Dec 12, 2025 | Lippis Daniel J. Officer (CVP, JAPAC) | Open-market sale | −1,019 | $84.03 | $85,627 |
| Dec 12, 2025 | BOBO DONALD E JR Officer (CVP,Strategy/Corp Development) | Gift | −7,100 | — | — |
| Dec 11, 2025 | Chopra Daveen Officer (CVP, TMTT & Surgical) | Open-market sale | −2,000 | $84.38 | $168,760 |
| Dec 10, 2025 | BOBO DONALD E JR Officer (CVP,Strategy/Corp Development) | Option exercise | +11,340 | $59.26 | $672,008 |
| Dec 10, 2025 | BOBO DONALD E JR Officer (CVP,Strategy/Corp Development) | Open-market sale | −11,340 | $83.83 | $950,632 |
| Dec 10, 2025 | Bernard J. Zovighian Director, Officer (CEO) | Open-market sale | −3,863 | $83.45 | $322,367 |
| Dec 9, 2025 | Scott B. Ullem Officer (CVP, Chief Financial Officer) | Option exercise | +7,700 | $59.26 | $456,302 |
| Dec 9, 2025 | Scott B. Ullem Officer (CVP, Chief Financial Officer) | Open-market sale | −7,700 | $84.47 | $650,419 |
| Dec 9, 2025 | Bernard J. Zovighian Director, Officer (CEO) | Gift | −3,863 | — | — |
| Dec 9, 2025 | Bernard J. Zovighian Director, Officer (CEO) | Gift | +3,863 | — | — |
| Dec 8, 2025 | Bernard J. Zovighian Director, Officer (CEO) | Option exercise | +25,350 | $59.26 | $1,502,241 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.